01 octubre 2020

PharmaMar . Fondos Americanos Entrando Uno Detrás de Otro Sin Pausas .

 Institutional Ownership and Shareholders .


PHMMF / Pharma Mar SA Institutional Ownership

Pharma Mar SA (US:PHMMF) has 57 institutional owners and shareholders that have filed 13D/G or 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 4,000,309 shares. Largest shareholders include VTMGX - Vanguard Developed Markets Index Fund Admiral Shares, SPDW - SPDR(R) Portfolio Developed World ex-US ETF, QCSTRX - Stock Account Class R1, JNL SERIES TRUST - JNL Multi-Manager International Small Cap Fund (A), SCHC - Schwab International Small-Cap Equity ETF, VGTSX - Vanguard Total International Stock Index Fund Investor Shares, SIDVX - Hartford Schroders International Multi-Cap Value Fund Class A, CIISX - Causeway International Small Cap Fund Institutional Class, Advanced Series Trust - Ast Prudential Growth Allocation Portfolio, and Dfa Investment Trust Co - The Continental Small Company Series.


Pharma Mar SA (US:PHMMF) institutional ownership structure shows current positions in the company by institutions and funds, as well as latest changes in position size. Major shareholders can include individual investors, mutual funds, hedge funds, or institutions. The Schedule 13D indicates that the investor holds (or held) more than 5% of the company and intends (or intended) to actively pursue a change in business strategy. Schedule 13G indicates a passive investment of over 5%.